Recurrent SARS-CoV-2 RNA Detection after COVID-19 Illness Onset during Pregnancy

Details

• Alternative Title:
  Emerg Infect Dis
• Personal Author:
  Griffin, Isabel ; Woodworth, Kate R. ; Galang, Romeo R. ; Burkel, Veronica K. ; Neelam, Varsha ; Siebman, Samantha ; Barton, Jerusha ; Manning, Susan E. ; Aveni, Kathryn ; Longcore, Nicole D. ; Harvey, Elizabeth M. ; Ngo, Van ; Mbotha, Deborah ; Chicchelly, Sarah ; Lush, Mamie ; Eckert, Valorie ; Dzimira, Paula ; Sokale, Ayomide ; Valencia-Prado, Miguel ; Azziz-Baumgartner, Eduardo ; MacNeil, Adam ; Gilboa, Suzanne M. ; Tong, Van T.
  More +
• Description:
  The Surveillance for Emerging Threats to Mothers and Babies Network conducts longitudinal surveillance of pregnant persons in the United States with laboratory-confirmed severe acute respiratory syndrome coronavirus 2 infection during pregnancy. Of 6,551 infected pregnant persons in this analysis, 142 (2.2%) had positive RNA tests >90 days and up to 416 days after infection.
• Subjects:
  • Covid-19
  • Female
  • Humans
  • Laboratories
  • Pregnancy
  • Pregnancy Complications, Infectious
  • Rna, Viral
  • Sars-Cov-2
  • Serologic Tests
• Source:
  Emerg Infect Dis. 2022; 28(4):873-876
• Pubmed ID:
  35213801
• Pubmed Central ID:
  PMC8962892
• Document Type:
  Letter
• Place as Subject:
  United States
• Volume:
  28
• Issue:
  4
• Download URL:
  https://stacks.cdc.gov/view/cdc/116343/cdc_116343_DS1.pdf
• File Type:
  [PDF - 784.21 KB]
• Collection(s):
  Emerging Infectious Diseases
• Main Document Checksum:
  urn:sha256:33e228b171674f0faa650915bac42548d7c246c5b986ebe512d74750461a36fd